BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center For Technology Licensing - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ctl.cornell.edu
X-WR-CALDESC:Events for Center For Technology Licensing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240228T100000
DTEND;TZID=America/New_York:20240228T170000
DTSTAMP:20260412T010536
CREATED:20240205T142639Z
LAST-MODIFIED:20240205T142639Z
UID:10000482-1709114400-1709139600@ctl.cornell.edu
SUMMARY:Annual Weill Cornell Medicine Startup Symposium & InvestConnect Conference
DESCRIPTION:You are invited to join the annual Weill Cornell Medicine Startup Symposium & InvestConnect Conference on Wednesday\, February 28\, 10:00 a.m.- 5:00 p.m. ET.  This full-day program is an opportunity to celebrate innovation &  entrepreneurship and engage with like-minded founders\, investors and industry representatives. Featured presentations will include: \n– An interview with Bruce R.\, Weill Cornell Medicine Board of Fellows member\, and Adam Bonislawski\, Editor with GenomeWeb\, co-authors of Early Detection: Catching Cancer When It’s Curable. In addition to being a prolific NYC real estate developer and philanthropist\, Mr. Ratner is the founder of the Michael D. Ratner Center for Early Detection of Cancer\, a non-profit established in the name of his older brother who passed away from metastatic cancer. He also sits on the boards of Memorial Sloan Kettering Cancer Center and the Cold Spring Harbor Laboratory. This lunchtime interview will be moderated by John Leonard\, M.D.\, Senior Associate Dean for Innovation and Initiatives. \n– A discussion on therapeutics with Barry Kappel\, Ph.D. ‘06\, Founder\, President & CEO of Sapience Therapeutics\, Inc. \n– An update on a novel neurotech startup being formed by Nicholas D. Schiff\, M.D. ’92\, the Jerald B. Katz Professor of Neurology and Neuroscience and Professor of Neuroscience at the Brain and Mind Research Institute. \n– A company update from Bernard Peperstraete\, MD\, MBA\, Co-Founder\, President & CEO of Acuamark Diagnostics\, Inc.\, a liquid biopsy company that is optimizing qPCR and dPCR for early detection of cancer. \nThe conference takes place on-campus at Belfer Research Building\, 413 E 69th St and will feature a startup expo and networking reception. Don’t miss out on an opportunity to meet WCM innovators and make impactful industry connections! \nhttps://2024startupsymposiumwcm.splashthat.com/
URL:https://ctl.cornell.edu/event/annual-weill-cornell-medicine-startup-symposium-investconnect-conference
CATEGORIES:CTL Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2024/02/Screenshot-2024-02-05-at-9.23.35-AM.png
END:VEVENT
END:VCALENDAR